Long term effects of phlebotomy on biochemical and histological parameters of chronic hepatitis C

American Journal of Gastroenterology

Volumn 97, Issue 1, 2002, Pages 133-137

  Yano, Motoyoshi ^a   Hayashi, Hisao ^b   Wakusawa, Shinya ^b   Sanae, Fujiko ^b   Takikawa, Toshikuni ^b   Shiono, Yuhta ^b   Arao, Motohiro ^b   Ukai, Koji ^b   Ito, Hiroshi ^b   Watanabe, Kazumasa ^b   Yoshioka, Kentaro ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Nagoya University School of Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; FERRITIN; INTERFERON;

ADULT; AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FERRITIN BLOOD LEVEL; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; MALE; PHLEBOTOMY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; BIOPSY, NEEDLE; FEMALE; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; IMMUNOHISTOCHEMISTRY; IRON OVERLOAD; LIVER CIRRHOSIS; LONG-TERM CARE; MALE; MIDDLE AGED; PHLEBOTOMY; PROBABILITY; REFERENCE VALUES; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 0036140561     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(01)03998-3     Document Type: Article

References (27)

1. National Institutes of Health Consensus Development Conference Panel statement: Management of hepatitis C
2. Response to interferon alpha-therapy is influenced by the iron content of the liver
3. Hepatic iron concentration as a predictor of response to alpha interferon therapy in chronic hepatitis C
4. Elevated serum iron predicts poor response to interferon treatment in patients with chronic HCV infection
5. Liver iron influences the response to interferon alpha therapy in chronic hepatitis C
6. Excess iron in the liver of patients with chronic hepatitis C
7. Measurements of iron status in patients with chronic hepatitis
8. Iron and chronic viral hepatitis
9. Threshold effect of liver iron content on hepatic inflammation and fibrosis in hepatitis B and C
10. Evaluation of iron status in patients with chronic hepatitis C
11. Role of iron load on fibrogenesis in chronic hepatitis C
12. Effects of iron loading on pathogenicity in hepatitis C virus-infected chimpanzees
13. Improvement of serum aminotransferase levels after phlebotomy in patients with chronic active hepatitis C and excess hepatic iron
14. Serum aminotransferase levels as an indicator of the effectiveness of venesection for chronic hepatitis C
15. Phlebotomy followed by alpha interferon therapy in patients with chronic hepatitis C
16. Classification of chronic hepatitis: Diagnosis, grading and staging
17. C282Y and H63D mutations in the HFE gene have no effect on iron overload disorders in Japan
18. Iron storage, lipid peroxidation and glutathione turnover in chronic anti-HCV positive hepatitis
19. A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C
20. Iron depletion is not effective in inducing a virologic response in patients with chronic hepatitis C who failed to respond to interferon therapy
21. Iron reduction before and during interferon therapy of chronic hepatitis C: Results of a multicenter, randomized, controlled trial
22. Iron reduction as an adjuvant to interferon therapy in patients with chronic hepatitis C who have previously not responded to interferon: A multicenter, prospective randomized, controlled trial
23. Hepatic iron storage in patients with chronic hepatitis C but no hepatic iron detectable histochemically
24. Iron stores, response to alpha-interferon therapy and effects of iron depletion in chronic hepatitis C
25. Therapy of hepatitis C: Other options
26. Peginterferon alfa-2a in patients with chronic hepatitis C
27. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis